Entry Detail



General Information

Database ID:exR0315902
RNA Name:hsa-miR-23a-3p
RNA Type:miRNA
Chromosome:chr19
Starnd:-
Coordinate:
Start Site(bp):13836595End Site(bp):13836615
External Links:hsa-miR-23a-3p



Disease Information

Disease Name:Benign Breast Disease
Disease Category:Other Diseases
MeSH ID:D001941
Type:Diseases Category/Skin and Connective Tissue Diseases
Alias:Breast Diseases//Breast Disease//Disease, Breast//Diseases, Breast//Endocrine Breast Diseases//Breast Disease, Endocrine//Breast Diseases, Endocrine//Disease, Endocrine Breast//Diseases, Endocrine Breast//Endocrine Breast Disease



Expression Detail

GEO ID:GSE73002
Description:A circulating microRNA panel to diagnose breast cancer
Experimental Design:Disease vs Control
Case Disease Type:Benign Breast Disease
Case Disease SubType:NA
Case Sample:Benign Breast Disease
Control Sample:Non-Cancer
Number of Case:54
Number of Control:2686
Number of Samples:2740





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ADGRG6
chr6
142301854
142446266
+
ATAD1
chr10
87751512
87841343
-
ATXN7L3
chr17
44191805
44200113
-
FKBP5
chr6
35573585
35728583
-
GATAD2B
chr1
153789030
153923360
-
IRF4
chr6
391752
411443
+
KLF12
chr13
73686089
73995056
-
PHLDA1
chr12
76025447
76033932
-
TK2
chr16
66508003
66552544
-
TNFAIP3
chr6
137867214
137883312
+
TOB2
chr22
41433494
41446801
-
USP54
chr10
73497538
73625953
-
VAT1
chr17
43014607
43025123
-
AC008758.1
chr19
12461559
12551474
-
ATP5MD
chr10
103389041
103396492
-
BACE2
chr21
41167801
41282530
+
GSTP1
chr11
67583742
67586656
+
ZNF709
chr19
12461184
12513854
-
ZNF91
chr19
23304991
23395471
-
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000384
chr12
27867712
27877119
+
hsa_circ_0000711
chr16
68155889
68160513
+
hsa_circ_0000881
chr19
5653125
5654467
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC007780.1
chr17
68413623
68524949
+
AC011503.2
chr19
23927788
23929287
+
AC078846.1
chr7
129604548
129611630
-
AC091564.7
chr11
6610883
6616594
-
AC124068.2
chr15
89335053
89336161
+
AC144548.1
chr12
110387463
110445548
-
AL035458.2
chr20
34234840
34281173
-
GAS5
chr1
173858559
173868882
-
MALAT1
chr11
65497688
65506516
+
MCM3AP-AS1
chr21
46229196
46259390
+
NEAT1
chr11
65422774
65445540
+
SNHG16
chr17
76557764
76565348
+
SNHG5
chr6
85650491
85678932
-
STAG3L5P-PVRIG2P-PILRB
chr7
100336104
100367831
+
TYMSOS
chr18
630886
658340
-
XIST
chrX
73820649
73852723
-
Z93241.1
chr22
42615244
42615907
+
ZNF674-AS1
chrX
46545438
46548841
+
Display:



Experiment Detail

GEO ID:GSE73002
Sample Source:Blood
Source Fraction:Serum
Platform:GPL18941
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:2512
Sample treatment protocol:NA
RNA Extract protocol:Total RNA was extracted each from 300uL serum samples using 3D-Gene® RNA extraction reagent from liquid sample kit (Toray Industries, Inc.).
RNA library preparation protocol:miRNA was labeled using 3D-Gene® miRNA Labeling kit in accordance with the manufacturer's instructions.



Reference

PMID:26749252
Title:Novel combination of serum microRNA for detecting breast cancer in the early stage
Author:Shimomura A, Shiino S, Kawauchi J, Takizawa S, Sakamoto H, Matsuzaki J, Ono M, Takeshita F, Niida S, Shimizu C, Fujiwara Y, Kinoshita T, Tamura K, Ochiya T
Journal:Cancer Sci. 2016 Mar;107(3):326-34.
Description:we examined the expression profiles of serum miRNA in several large cohorts to identify novel miRNA that can be used to detect early stage breast cancer.